Rejuvenate Biomed Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$18.3M
- Investors
-
6
Rejuvenate Biomed General Information
Description
Operator of a biomedical company intended to develop safe and synergistic combination drugs to delay the onset of age-related diseases. The company uses large datasets and applies network biology to identify drug combinations that can restore complex biological systems, enabling medical researchers to balance core biological processes associated with age-related functional decline.
Contact Information
Website
www.rejuvenatebiomed.comCorporate Office
- Agoralaan A-bis
- 3590 Diepenbeek
- Belgium
Corporate Office
- Agoralaan A-bis
- 3590 Diepenbeek
- Belgium
Rejuvenate Biomed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC (Series B) | 07-Aug-2025 | $18.3M | Completed | Generating Revenue | ||
| 5. Merger/Acquisition | 12-Oct-2021 | Cancelled | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 02-Mar-2021 | Completed | Generating Revenue | |||
| 3. Grant | 10-Aug-2018 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Mar-2018 | $528K | Completed | Startup | ||
| 1. Seed Round | 01-Nov-2017 | $528K | $528K | Completed | Startup |
Rejuvenate Biomed Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred Class C2 | ||||||||
| Preferred Class C1 | ||||||||
| Series B | ||||||||
| A2 Shares | 180,389 | $18.21 | $18.21 | 1x | $18.21 | 14.39% | ||
| A1 Shares | 46,155 | $11.34 | $11.34 | 1x | $11.34 | 0% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Rejuvenate Biomed Patents
Rejuvenate Biomed Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023376163-A1 | Galantamine minitablets | Pending | 07-Nov-2022 | ||
| EP-4615421-A1 | Galantamine minitablets | Active | 07-Nov-2022 | ||
| EP-4615421-B1 | Galantamine minitablets | Active | 07-Nov-2022 | ||
| EP-4615421-C0 | Galantamine minitablets | Active | 07-Nov-2022 | ||
| ES-3082869-T3 | Galantamine minitablets | Active | 07-Nov-2022 | A61K9/2095 |
Rejuvenate Biomed Signals
Rejuvenate Biomed Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Centenara Labs | Venture Capital | Minority | ||
| Dyfan Investment | Impact Investing | Minority | ||
| LRM | Venture Capital | Minority | ||
| Vesalius Biocapital Partners | Venture Capital | Minority | ||
| VLAIO | Limited Partner | Minority |
Rejuvenate Biomed FAQs
-
When was Rejuvenate Biomed founded?
Rejuvenate Biomed was founded in 2017.
-
Where is Rejuvenate Biomed headquartered?
Rejuvenate Biomed is headquartered in Diepenbeek, Belgium.
-
What is the size of Rejuvenate Biomed?
Rejuvenate Biomed has 15 total employees.
-
What industry is Rejuvenate Biomed in?
Rejuvenate Biomed’s primary industry is Drug Discovery.
-
Is Rejuvenate Biomed a private or public company?
Rejuvenate Biomed is a Private company.
-
What is the current valuation of Rejuvenate Biomed?
The current valuation of Rejuvenate Biomed is .
-
What is Rejuvenate Biomed’s current revenue?
The current revenue for Rejuvenate Biomed is .
-
How much funding has Rejuvenate Biomed raised over time?
Rejuvenate Biomed has raised $24M.
-
Who are Rejuvenate Biomed’s investors?
Centenara Labs, Dyfan Investment, LRM, Vesalius Biocapital Partners, and VLAIO are 5 of 6 investors who have invested in Rejuvenate Biomed.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process